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The effects on virus viability and reverse transcriptase (RT) function of substituting Trp for Tyr or Phe residues within the polymerase
domain of human immunodeficiency virus type 1 (HIV-1) RT have been analyzed with an infectious HIV-1 clone. Viruses containing
mutations Y56W, F61W, F87W, F116W, Y127W, Y144W, F171W, Y181W, Y183W, Y188W, F227W, or Y232W in their RT-coding regions
were viable and showed replication capacities similar or slightly reduced in comparison with the wild-type HIV-1. However, RTs bearing
mutations F77W or Y146W had a dNTP-binding defect, rendering nonviable viruses. HIV-1 carrying RT mutations F124W or F130W
replicated very poorly, but compensatory changes (K83R for F124W, and T58S for F130W) were selected upon passaging the virus in cell
culture. The amino acid substitution F130W diminishes the stability of the 51-kDa subunit of the RT (p51) and impairs polyprotein
processing in virus-infected cells, an effect that can be mitigated when T58S is found in p51.
D 2004 Elsevier Inc. All rights reserved.Keywords: HIV; Reverse transcriptase; Fitness; Polymerase; Drug resistance; Retrovirus; Mutagenesis
66 kDa (p66) and 51 kDa (p51). Subdomains within eachIntroduction
The human immunodeficiency virus type 1 (HIV-1) re-
verse transcriptase (RT) catalyzes the synthesis of proviral
DNA using the viral RNA as template (for a review, see
Telesnitsky and Goff, 1997). It is a multifunctional enzyme,
possessing RNA- and DNA-dependent DNA polymerase,
RNase H, strand transfer, and strand-displacement activities.
The process of reverse transcription is error prone and
contributes to the high genetic variability of HIV-1 (for recent
reviews, see Mene´ndez-Arias, 2002a; Svarovskaia et al.,
2003). HIV-1 RT is a heterodimer composed of subunits of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 Present address: CISA-INIA, Valdeolmos, Madrid, Spain.subunit are termed ‘‘fingers’’, ‘‘palm’’, ‘‘thumb’’, and ‘‘con-
nection’’ based on X-ray crystal structure and standard
subdomain classification in various polymerases (Kohlstaedt
et al., 1992; Joyce and Steitz, 1995). The heterodimer is
generated after the viral protease cleaves one of the RNase H
domains of an asymmetric p66/p66 homodimer (Di Marzo
Veronese et al., 1986). The DNA-binding cleft and the
polymerase active-site residues are exposed in the ‘‘open’’
conformation of p66. On the other hand, the 51-kDa subunit
is closely folded, with its catalytic residues occupying an
internal position in the molecule (Ding et al., 1998; Huang et
al., 1998; Kohlstaedt et al., 1992). In addition to its structural
role, p51 has been implicated in loading the p66 subunit on
the template-primer (Harris et al., 1998) and in maintaining
the proper conformation of p66 during initiation of reverse
transcription (Arts et al., 1996).
Table 1
Maximum levels of RT activity in culture supernatants from cells
transfected with HIV-1 cDNA clones carrying mutations in the RT-coding
regiona
Mutation Day RT activity (%)
WT 12 100
Y56W 12 90
F61W 16 60
F77W n.d.b n.d.
F87W 12 85
F116W 14 100
F124W 16 14
Y127W 12 90
F130W 19 17
Y144W 12 90
Y146W n.d. n.d.
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main of retroviral RTs have revealed a series of homology
regions that are conserved in RT-related DNA polymerases as
well as in RNA-dependent RNA polymerases (Nakamura et
al., 1997; O’Reilly and Kao, 1998; Xiong and Eickbush,
1990). Conserved regions include motifs 1 and 2 in the
fingers subdomain, which contain residues such as Lys-65
and Arg-72 that participate in triphosphate binding, and
motifs A, BV, C, D, and E that contain residues within the
fingers and palm subdomains of the RT. The catalytic
residues are found in motifs A (Asp-110) and C (Asp-185
and Asp-186). Motif BV participates in dNTP binding through
Gln-151, which is part of the highly conserved sequence Leu-
Pro-Gln-Gly, and motif E is part of the ‘‘primer grip’’ formed
by residues involved in maintaining the primer terminus in an
appropriate orientation for nucleophilic attack of an incoming
dNTP (Ding et al., 1998; Huang et al., 1998).
Aromatic residues such as Tyr-115 and Phe-160 within
motifs A and BV, respectively, are important to maintain the
integrity of the dNTP binding site, and nonconservative
substitutions at these positions lead to the loss of RT
function and virus viability (Cases-Gonza´lez et al., 2000;
Gutie´rrez-Rivas et al., 1999; Martı´n-Herna´ndez et al., 1996;
Olivares et al., 1999). Previously, we showed that the
substitution of Trp for Tyr-115 impaired DNA polymerase
activity and rendered a virus that replicated very poorly in
MT-4 cells. However, in transfection experiments carried
out with proviral DNA having the RT mutation Y115W, we
found a compensatory substitution in motif E (M230I) that
restored the replication capacity of the virus (Olivares et al.,
1999). The emergence of a second-site revertant was fa-
vored by the requirement of two simultaneous nucleotide
substitutions to convert the Trp codon (UGG) into a Tyr
codon (UAU, UAC). In this work, we have extended our
analysis to the other Tyr and Phe residues located within
positions 40 and 240 of the RT polymerase domain, which
include the conserved motifs 1, 2, A, BV, C, D, and E.
Sixteen mutant proviruses containing Phe!Trp or Tyr!Trp
substitutions were obtained and assayed for viability, and
RTs from viruses showing diminished replication capacity
were purified and characterized. A novel compensatory
mutation in p51 was identified after passaging in cell culture
a replication-deficient virus carrying the mutation F130W.F171W 12 101
Y181W 14 70
Y183W 12 70
Y188W 10 65
F227W 12 125
Y232W 12 89
a RT activity was monitored periodically in the cell culture medium of all
transfections. Reported data refer to the day after transfection when the peak
of RTactivity was observed. RTactivity values are referred to those obtained
with cultures transfected with WT HIV-1. One microliter of culture
supernatant produced 10,000 photo-stimulated light emission (PSL) units.
b n.d. stands for not detected. RT activity levels were not distinguishable
from background (mock-infected cells) at all times tested (up to 50 days
after transfection). Same results were obtained in at least three independent
experiments.Results
In vitro replication of HIV-1 mutants
The effects on virus replication of substituting Trp for Tyr
or Phe at different positions of the RT polymerase domain
were assessed after introducing the corresponding mutations
into the proviral genome. COS-1 cells were transfected with
WT (HIV-1 subtype B strain 89ES061) or mutated proviral
DNA, and after addition of MT-4 cells, co-culture super-
natants were monitored at various times for RT activity.Maximum levels of RT activity were detected 12 days after
transfection withWTDNA (Table 1), and similar results were
obtained with mutants Y56W, F87W, F116W, Y127W,
Y144W, F171W, Y181W, Y183W, Y188W, F227W, and
Y232W that showed RT activity peaks between days 10
and 14. Mutants F61W, F124W, and F130W emerged later,
showing maximum levels of RT activity at days 16–19. The
RT activity detected in culture supernatants of mutants
F124Wand F130W was also very low, representing less than
20% of that shown by cultures transfected with the WT
provirus. Viruses recovered from those cultures transfected
with mutants F124W and F130W were viable, and their RT-
coding sequence was identical to the one present in the
proviral DNA. Reversions or additional mutations in the
RT-coding region were not found in the progeny virus in
any of the described transfection experiments. Virus titers of
mutants F124W and F130W were usually around 104 50%
tissue culture infective doses (TCID50) per ml, while the other
viable mutants showed titers similar to the WT virus, and in
the range of 105 to 106 TCID50 per ml.
Cultures transfected with mutants F77W and Y146W
failed to produce any detectable RT activity even after 50
days of culture (values indistinguishable from those
obtained in mock-transfection assays), were negative for
the presence of p24, and supernatants from those cultures
were unable to infect MT-4 cells.
The replication capacity of all viable mutants was deter-
mined upon infection of MT-4 cells by monitoring RT
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replication kinetics in comparison with WT HIV-1, with
peaks of RT activity between days 7 and 9, and RT activity
and p24 antigen levels above 60% of the WT virus (Fig. 1).
However, mutants F124W and F130W showed impaired
replication capacity with RT activity levels below 20% of
the WT virus, and reduced amounts of p24 in culture
supernatants.
Enzymatic characterization of RT mutants
The RT polymerase activity conferred by mutations show-
ing the largest effects on viral replication capacity (e.g.,
F61W, F77L, F124W, F130W and Y146W) was determined
with the corresponding recombinant RTs. F116W was also
included in this analysis as an example of a mutation
producing a minor effect on viral replication. Expression
and purification of all mutant RTs were rather efficient,
except in the case of F130W. No protein was recovered when
the mutation F130W was present in p51, as found with
heterodimers p66F130W/p51F130W (designated as F130W) or
p66WT/p51F130W, suggesting that Phe-130 could be important
to maintain the stability of p51. After induction with isopro-
pyl-h-D-thiogalactopyranoside, the p51 subunit carrying the
mutation F130W was expressed at levels below 10% of
those observed with the WT polypeptide and was found to
be very sensitive to proteolytic degradation during the
purification process (data not shown). On the other hand,
the heterodimeric RT containing the mutation F130W in
p66, but having a WT p51 (p66F130W/p51WT), was purifiedFig. 1. Replication kinetics of WT and mutant HIV-1 in MT-4 cells. MT-4 cells
corresponding mutants. Samples were withdrawn from the infected cultures at th
poly(rA)/oligo(dT)12 – 18 and [
32P]dTTP as substrates. RT activity and p24 antigen
the WT virus. Interassay variability was below 15%.in significant amounts and had a DNA-dependent DNA
polymerase activity similar to that shown by the WT enzyme
(Fig. 2). Qualitative assessments of the DNA polymerase
activity of the mutant RTs, based on primer extension
assays, indicated that Y146W and particularly F77W have
a strongly impaired polymerase activity (Fig. 2).
Steady-state kinetic analysis of nucleotide incorporation
by WT and mutant RTs revealed large differences between
the WT enzyme and mutants F77W and Y146W (Table 2).
The catalytic efficiencies of those mutants were reduced by
50-fold in comparison with WT RT due to their relatively
high Km values. Reduced catalytic efficiency appears as the
likely cause of the replication defect observed in viruses
containing mutations F77W or Y146W. Other tested muta-
tions had a small effect on DNA polymerase activity, and
their catalytic efficiencies were within a 2.5-fold range
compared with the WT RT.
Analysis of compensatory mutations arising after passaging
replication-deficient virus in cell culture
Viral replication assays showed that mutations F124W
and F130W were the ones that produced the largest effect
while maintaining virus viability. In an attempt to improve
viral fitness, HIV-1 (strain 89ES061) bearing mutations
F124W or F130W was passaged in MT-2 cells. In general,
a new passage was done when cell viability decreased to
less than 40%. At first, passages were carried out every 8–
10 days, but cell viability decreased more rapidly in suc-
cessive passages. At passage 8 with F124W or passage 6(106) were infected with 0.0001 TCDI50 per cell with viral stocks of the
e indicated times and virion-associated RT activity was determined using
levels at day 8 are given as percentages of the measurements obtained with
Fig. 2. Extension of primer 3TRP by WT and mutant RTs in assays containing a DNA template (M_54) and a mixture of dNTPs at a concentration of 0.5 mM
each. Template-primer concentration was 30 nM, and reactions were incubated for 5, 15, 30, and 60 min (lanes 1–4) in the presence of a 12-nM concentration
of each enzyme. P and E indicate the positions of the primer and the fully extended product, respectively. The sequence of the template-primer (M_54/3TRP) is
given below.
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4 days. Nucleotide sequencing of the gag and pol genes of
virus recovered at passage 8 showed that for mutant F124W,Table 2
Kinetic parameters for dNTP incorporation of WT and mutant RTsa
Enzyme kcat (min
1) Km (AM) kcat/Km (min1 AM1)
WT 2.77 F 1.28 0.32 F 0.10 8.66 F 2.27
F61W 1.50 F 0.29 0.44 F 0.19 3.39 F 0.02 (0.4)b
F77W 2.39 F 0.28 >100 <0.02 (<0.005)
F116W 1.00 F 0.24 0.073 F 0.046 13.7 F 4.9 (1.6)
F124W 1.00 F 0.18 0.051 F 0.027 19.6 F 10.3 (2.3)
p66F130W/p51WT 2.75 F 0.46 0.38 F 0.07 7.57 F 2.68 (0.9)
Y146W 1.98 F 0.79 12.2 F 5.0 0.18 F 0.11 (0.02)
a The template-primer used in these assays (D2–47/PG5–25) was 5V-
GGGATTAAATAAAATAGTAAGAATGTATAGCCCTACCAG-
CATTCTGG-3V and 3V-TACATATCGGGATGGTCGTAAGACC-5V. Elon-
gation reactions were incubated for 0–90 s for the incorporation of T. Data
shown are the mean valuesF standard deviations obtained from a nonlinear
least square fit of the kinetics data to the Michaelis-Menten equation. Each
of the experiments was performed independently at least twice. Mutations
were introduced in both subunits of the heterodimer, except in the case of
p66F130W/p51WT. Superscripts are used to indicate the amino acid
substitutions found in each subunit.
b Values between parenthesis represent the ratio of the catalytic efficiency
of each mutant enzyme relative to that shown by the WT RT.there was only one additional mutation, which was located
at position 83 of the RT (K83R). In the case of mutant
F130W, we found that the RT-coding region of virus
recovered at passage 6 contained only one additional amino
acid substitution (T58S) in comparison with the RT of the
initial virus population, while no other mutations were
found in the gag and pol genes.
Stocks of virus recovered from passage 6 or 8 in both
experiments were obtained, titrated, and used to infect MT-4
cells. The growth curves of WT HIV-1 and mutants F124W,
F130W, K83R/F124W, and T58S/F130W are shown in Fig.
3. For the WT virus, maximum RT activity was detected 7
days after infection, while cell viability decreased below
20%. Interestingly, the double-mutant K83R/F124W
showed increased RT activity in viral supernatants and
higher cytopathicity in comparison with the single-mutant
F124W (Fig. 3A). However, the double-mutant K83R/
F124W was still less virulent than the WT virus. On the
other hand, T58S has a strong compensatory effect on the
replication of mutant HIV-1 harboring mutation F130W
(Fig. 3B). The RT activity in the supernatants of cultures
infected with virus containing mutations T58S and F130W
increased by more than 20-fold at day 7 compared with the
single-mutant F130W. In addition, the cytopathic effect
Fig. 3. Replication kinetics of WT HIV-1, single mutants F124W and F130W, and double mutants K83R/F124W and T58S/F130W. MT-4 cells (106) were
infected at a multiplicity of infection of 0.0001 TCDI50 per cell. Infections were monitored by measuring RT activity (left) and cell viability (right). (A)
Comparison of WT HIV-1 (filled circles) with mutants F124W (filled squares) and K83R/F124W (open diamonds). (B) Comparison of WT HIV-1 with
mutants F130W (open triangles) and T58S/F130W (open squares).
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that observed with the WT virus.
Western blot analysis of the time course of infection
with WT HIV-1 and mutants F130W and T58S/F130W
was carried out with antibodies recognizing the viral capsid
protein p24 (Fig. 4). In agreement with results described
above, virus production was delayed in the case of mutant
F130W (Fig. 4B) in comparison with the WT virus and the
double-mutant T58S/F130W (Figs. 4A and C). Large
amounts of p24 and the 55-kDa Gag precursor were
observed in cells infected with all three viruses. However,
a large amount of mature p24 relative to its Gag precursor
was found only in virions from cell cultures infected with
WT HIV-1 and mutant T58S/F130W. In the case of mutant
F130W, the presence of significant amounts of unprocessed
Gag in viral particles is consistent with an inefficient
processing of the polyprotein precursor that delays virus
maturation.
Further evidence of the compensatory effect of T58S
was obtained from kinetic studies using recombinant
RTs. Mutants T58S (p66T58S/p51T58S), T58S/F130W
(p66T58S/F130W/p51T58S/F130W), and p66WT/p51T58S/F130W
showed high catalytic efficiency for nucleotide incorpo-
ration in DNA polymerase assays (Table 4). According
to these data, the compensatory role of T58S can be
attributed to the presence of both amino acid substitu-
tions (T58S and F130W) in the 51-kDa subunit of HIV-
1 RT, as demonstrated by using chimeric heterodimers
where substitutions were introduced in p66, p51, or both
subunits (Tables 2 and 3).Discussion
The HIV-1 RT contains nine Phe and nine Tyr residues
within the conserved motifs of DNA polymerases (Xiong
and Eickbush, 1990). All of these residues are highly
conserved among HIV-1 isolates from untreated individuals
(Rhee et al., 2003). Frequent resistance mutations involving
Tyr or Phe residues within the RT polymerase domain are
F77L, F116Y, Y181C, Y188L, and F227L (reviewed in
Mene´ndez-Arias, 2002b). Analysis of the crystal structure of
the enzyme (Ding et al., 1998; Huang et al., 1998; Kohl-
staedt et al., 1992) has shown that the side-chains of five
residues within p66 (Phe-61, Tyr-115, Tyr-127, Tyr-181 and
Tyr-183) and six residues within p51 (Phe-87, Phe-116, Tyr-
127, Tyr-183, Phe-227 and Trp-229) are exposed to the
solvent (e.g., residues with solvent-accessible surfaces be-
low 10% of the maximum, as determined for the
corresponding amino acid in an extended conformation).
Phe-61, Tyr-115, and Tyr-183 of the 66-kDa subunit are
involved in interactions with the template primer or the
incoming dNTP. Phe-61 contacts the first and second bases
of the 5V-template overhang, the side-chain of Tyr-115
interacts with the ribose moiety of the nucleotide substrate,
and Tyr-183 contacts the primer strand, at its 3V end (Huang
et al., 1998). Previous studies showed that recombinant RTs
bearing mutations Y56W, F61W, Y181W, or Y232W
retained high levels of DNA polymerase activity (Boyer et
al., 1992; Fisher and Prasad, 2002; Ghosh et al., 1997;
Sardana et al., 1992), while F87W has been found in one
clinical isolate (Beerenwinkel et al., 2002). Nucleotide
Fig. 4. Western blot detection of HIV-1 p24 in MT-4 cells infected with WT
virus and mutants F130W and T58S/F130W. MT-4 cells were infected with
0.0001 TDCI50 per cell and aliquots of culture supernatants and cells were
collected daily until cell viability decreased to less than 10%. Infections
were monitored by measuring RT activity, and representative aliquots were
subjected to immunoblotting. The pellets obtained after processing 105 cells
or 100 Al of culture supernatant were applied in SDS-polyacrylamide gels,
and after electrotransfer, blots were developed with specific mouse
monoclonal antibodies against p24. Western blots show the Gag processing
time course of cultures infected with WT HIV-1 (A), mutant F130W (B),
and the double-mutant T58S/F130W (C). Blots shown on the left were
obtained with cell lysates, while those on the right were derived from the
analysis of supernatant virions. A loading control for the cell lysate,
obtained using a h-actin-specific antibody, is shown below each panel. m
stands for mock-infected cells. Prestained protein molecular mass markers
from Sigma were used as references. The electrophoretic mobilities of p24
and the 41- and 55-kDa precursors of p24 (p41 and Gag, respectively) are
also indicated.
Table 3
Kinetic parameters for dNTP incorporation of RTs containing the amino
acid substitution T58Sa
Enzyme kcat (min
1) Km (AM) kcat/Km
(min1 AM1)
T58S 0.71 F 0.10 0.097 F 0.012 7.29 F 0.08
T58S/F130W 0.78 F 0.06 0.183 F 0.039 4.34 F 0.90
p66WT/p51T58S/F130W 0.98 F 0.16 0.155 F 0.024 6.33 F 0.62
a The template-primer used in these assays (D2–47/PG5–25) is given in
Table 2. Elongation reactions were incubated for 0–90 s for the
incorporation of T. Data shown are the mean values F standard deviations
obtained from a nonlinear least square fit of the kinetics data to the
Michaelis-Menten equation. Each of the experiments was performed
independently at least twice. Mutations were introduced in both subunits of
the heterodimer, except in the case of p66WT/p51T58S/F130W. Superscripts
are used to indicate the amino acid substitutions found in each subunit.
I. Olivares et al. / Virology 324 (2004) 400–411 405incorporation kinetics for mutant F61W and WT HIV-1 RT
were rather similar (Fisher and Prasad, 2002), in agreement
with data reported in this paper. However, Fisher et al.
(2003) have shown that mutation F61W has a negative
effect on the enzyme’s ability to catalyze strand displace-ment synthesis on nicked and gapped duplex DNA tem-
plates. This alteration could explain the small reduction in
viral replication capacity observed in our assays, with the
mutant virus in comparison with the WT HIV-1. Our data
indicate that most Phe and Tyr residues within the poly-
merase domain of HIV-1 RT can be replaced by Trp without
major alterations of DNA polymerase function and virus
viability.
In addition to Tyr-115 and Phe-160 of HIV-1 RT, whose
replacement by Trp impairs dNTP binding during DNA
polymerization, and have a deleterious effect on viral
replication (Cases-Gonza´lez et al., 2000; Gutie´rrez-Rivas
et al., 1999; Martı´n-Herna´ndez et al., 1996; Olivares et al.,
1999), we found that substituting Trp for Phe-77 or Tyr-146
rendered nonviable virus, while mutants having Trp instead
of Phe at positions 124 or 130 had a strongly diminished
replication capacity. DNA polymerization assays showed
that RTs carrying mutations F77W or Y146W had a very
low catalytic efficiency for nucleotide incorporation due to
their high apparent Km values. Phe-77 is in the fingers
subdomain and contacts Gln-151, whose side-chain inter-
acts with the incoming nucleotide. The substitution of Leu
for Phe-77 is usually associated with Q151M, and is
commonly found in clinical isolates from patients treated
with multiple nucleoside analogues (Shirasaka et al., 1995).
This amino acid change leads to a side-chain volume
reduction that does not affect the RT’s DNA polymerase
activity. In contrast, the substitution of Trp for Phe leads to
a 29.2% increase of the side-chain volume that probably
alters the conformation of the dNTP binding site in HIV-1
RT.
A similar mechanism could be invoked to explain the
deleterious effect of Y146W. Tyr-146 occupies an internal
position in both RT subunits, with less than 2% of its side-
chain exposed to the solvent. Amino acids near Tyr-146
are Lys-46, Lys-73, Val-75, Arg-125, Thr-128, Phe-130,
Gln-145, and Val-148, as well as dNTP-binding-site resi-
dues such as Phe-116 and Gln-151. Amino acid substitu-
tions at position 146 are rare among HIV-1 clinical isolates
(Rhee et al., 2003), and the Y146W mutation has not been
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found at the equivalent position of Tyr-146 of HIV-1 RT in
other retroviral RTs, including those from murine leukemia
virus, equine infectious anemia virus, human T cell leuke-
mia virus types I and II, and mouse mammary tumor virus,
among others (Xiong and Eickbush, 1990). Our data show
that the recombinant RT bearing mutation Y146W has an
impaired dNTP binding ability. This is probably due to an
alteration of the conformation around the dNTP binding
site in the 66-kDa subunit of the polymerase as a conse-
quence of the packaging defect caused by the substitution
of Trp for Tyr-146.
Compensatory mutations play a key role in virus adap-
tation. Thus, evolution of drug resistance is characterized by
small to severe fitness losses that can be partially overcome
by compensatory mutations or other adaptative changes that
restore viral replication capacity (for a recent review, see
Mene´ndez-Arias et al., 2003). Amino acid substitutions
affecting aromatic residues within the RT polymerase do-
main that produce a drastic loss of viral replication capacity
(e.g., Y115W or W229Y) can be compensated through the
acquisition of second-site reversions that improve viral
fitness. Examples are M230I for Y115W (Olivares et al.,
1999) or the combination of I63M, V189I, and E369G for
W229Y (Pelemans et al., 2001). In the first case, the double-
mutant (Y115W/M230I) displayed WT replication capacity
and emerged around 30–45 days after transfection, using
the methodology described in this paper.
Emergence of second-site revertants was not observed
at the end of transfection experiments with any of the
mutants tested in this work. However, compensatory
mutations were selected after passaging in cell culture
the replication-deficient mutants F124W and F130W. The
RT mutation K83R produced a partial but significant
increase of the viral replication capacity of mutant virus
harboring mutation F124W. The large impact of this
mutation on viral replication capacity is difficult to
explain from a structural point of view, because this
residue is buried in the RT molecule and does not appear
to be involved in functionally important interactions, such
as template-primer binding, dNTP incorporation, or sta-
bilization of the RT heterodimer. Besides, characterization
of recombinant HIV-1 RT containing Trp at position 124
showed that this enzyme displayed DNA polymerase
activity and nucleotide incorporation efficiency similar
to those observed with the WT virus. Nevertheless, it
should be noted that the RT of HIV-189ES061 contains Lys
at position 83, instead of Arg as found in the recombi-
nant RT used in our studies, that derives from HIV-1
strain BH10.
Phe-130 and Tyr-183 are the only aromatic amino acid
residues of the HIV-1 RT polymerase domain that are
strictly conserved in all retroviral RTs. The side-chain of
Phe-130 is buried within the protein core in both RT
subunits. RT heterodimers having the F130W substitution
in p66 showed WT DNA polymerase activity. However,repeated attempts to express and purify RTs containing
this mutation in p51 failed as a consequence of the lower
stability of the 51-kDa subunit. The reasons of this
stability loss are uncertain, although improper folding of
p51, impaired RT heterodimerization, or higher suscepti-
bility to proteases appear as likely causes of this defect.
Interestingly, successive passages of the virus in cell
culture led to selection of T58S as a second-site mutation
that restored viral replication capacity in virus containing
the RT mutation F130W.
Analyses of HIV-1 RT crystal structures indicate that Thr-
58 interacts with Phe-130 (Fig. 5A). Thus, the closest
distances between both residues in the ternary complex
composed of HIV-1 RT, a template-primer, and an incoming
dNTP (Huang et al., 1998) are 3.12 and 3.57 A˚, for p51 and
p66, respectively, which correspond to the distance between
the -CO- group of Thr-58 and the Ch atom of Phe-130.
Similar distances were obtained with the coordinates of
unliganded HIV-1 RT (Esnouf et al., 1995) and with
coordinates of the enzyme complexed with a double-strand-
ed DNA/DNA template-primer (Ding et al., 1998). Thr-58 is
located within motif 1 in the fingers subdomain and is
conserved in most retroviral RTs, including HIV-1 and other
lentiviral polymerases (Xiong and Eickbush, 1990). Bio-
chemical evidence reveals that the compensatory effect of
the T58S mutation is mediated by p51. Thus, RTs containing
both amino acid substitutions in p51 (e.g., p66T58S/F130W/
p51T58S/F130W and p66WT/p51T58S/F130W) were successfully
expressed and purified, and showed kinetic properties
similar to those displayed with the WT recombinant
enzyme. In addition to the structural role, residues near
Phe-130 such as Asn-57 and Arg-143 contribute to inter-
actions with Trp-88 of the 66-kDa subunit (Fig. 5B) and
could affect RT heterodimerization (Mene´ndez-Arias et al.,
2001).
Western blot analysis confirmed that viral replication of
mutant F130W was delayed in comparison with the WT
HIV-1 or the double-mutant T58S/F130W. Although virions
from cells infected with all three viruses contained signif-
icant levels of p24, we found large differences in the relative
amounts of unprocessed Gag found in viral particles. Thus,
the Gag precursor polypeptide was almost undetectable in
the WT and T58S/F130W virions, but was present in large
amounts in viral particles containing the mutation F130W in
their RT-coding region (Fig. 4). These results show that
F130W has a deleterious effect on virus maturation. Ineffi-
cient folding of one of the RT subunits is likely to impair the
Pol dimerization process required to activate the viral
protease.
There are very few examples of mutations in p51
affecting RT function. Thus, residues 136–139 of the
h7–h8 loop of p51 are required to obtain functionally
active RT heterodimers (Pandey et al., 2001), and the
substitution of Glu-138 by Lys on the p51 subunit has
been shown to confer resistance to various non-nucleoside
RT inhibitors (Jonckheere et al., 1994; reviewed in Mene´n-
Fig. 5. Location of Thr-58 and Phe-130 in the crystallographic structure of
HIV-1 RT. (A) Ribbon representation of the p66 (blue) and p51 (green)
subunits of the RT complexed with a DNA/DNA template-primer (template
shown in red, and primer in white) and dTTP, showing the location of
residues 58 and 130 in both RT subunits. (B) Residues of p51 near Thr-58
and Phe-130. Van der Waals surfaces of these residues are shown in yellow,
while those of amino acids within 3.5 A˚ of Thr-58 and Phe-130 are shown
in blue (Asn-57, Thr-58, Pro-59, Lys-73, Asp-76, Ala-129, Thr-131, Arg-
143, and Tyr-144). Trp-88 of p66 (magenta) interacts with p51 through
residues Asn-57 and Arg-143.
I. Olivares et al. / Virology 324 (2004) 400–411 407dez-Arias, 2002b). However, our study is the first report
where the structural integrity of p51 affecting the activity
of the heterodimer is clearly demonstrated with virological
studies. Furthermore, our results provide the first example
of a compensatory mutation acting through p51. These
findings illustrate the enormous adaptative potential of
HIV-1 and should help in designing new strategies to
abrogate RT function through a better knowledge of the
molecular determinants involved in the formation of RT
heterodimers.Materials and methods
Cell lines and molecular clones
COS-1 cells and MT-4 cells were maintained as mono-
layer and suspension cultures, respectively, in RPMI 1640
medium supplemented with 10% fetal bovine serum and 2
mM glutamine. Virus used in this study was an infectious
molecular clone of HIV-1 isolate 89ES061 previously
described (Olivares et al., 1997, 1998). The 5V end of the
proviral DNA, including the 5V long-terminal-repeat (LTR)
region and the viral genes gag, pol, and vif, was cloned in
the XbaI and EcoRI sites of plasmid pBSK (Stratagene) to
obtain plasmid p61F A. The 3V end of the proviral DNA,
including the env gene and the 3V LTR, was cloned in pBSK
at the EcoRI and XbaI sites to generate plasmid p61F B. Co-
transfection with plasmids p61F A and p61F B renders
infectious virus after in vivo ligation (Olivares et al., 1997).
Mutant HIV clones were obtained by site-directed muta-
genesis using the QuikChange Site-Directed Mutagenesis
Kit (Stratagene) by following the manufacturer’s instruc-
tions. Mutations were introduced in plasmid p61F A using
the primers shown in Table 4. Mutations were verified by
DNA sequencing of the RT-coding region.
DNA transfection experiments
Transfections were performed as previously reported
(Olivares et al., 1997). Briefly, 3  106 COS-1 cells were
electroporated with 10 Ag of subgenomic clones p61FA and
p61F B. Forty-eight hours after transfection, 4  106 MT-4
cells were added to the culture. Viral replication was
monitored by RT activity and p24 antigen detection in
culture supernatants. Virion-associated RT activity was
determined as described by Willey et al. (1988), after
mixing 10 Al of transfection supernatant with 50 Al of an
RT reaction mixture that contained a template-primer of
poly(rA) (5 Ag ml1) and oligo(dT)12–18 (1.57 Ag ml1) in
50 mM Tris, pH 7.8, 75 mM KCl, 2 mM dithiothreitol, 5
mM MgCl2, 0.05% Nonidet P-40, and 0.5 ACi of [32P]dTTP
(800 Ci mmol1). Incorporated dTTP was estimated by
phosphorimaging with a Fujifilm FLA-3000 scanner and the
TINA 2.0 program. Production of p24 antigen in cell-free
supernatants was measured using an antigen capture kit
(SAIC Frederick, AIDS Vaccine Program).
Infections
To obtain a virus stock, supernatants from transfection
experiments collected at days when maximum levels of RT
activity were detected were used to infect 5  106 fresh MT-
4 cells. Viral stocks were titrated in MT-2 cells and titers
were calculated by the Spearman-Karber method (Mascola,
1999), and expressed as TCID50. Infections were then
carried out at a multiplicity of infection of 102 to 105
TCID50 per cell. Viral replication was monitored by mea-
Table 4
Synthetic oligonucleotides used in site-directed mutagenesis reactions
Template Mutation Primers
p61F A Y56W 5V-CGGGCCTGAAAATCCATGGAATACTCCAGTATTTGCC-3V
5V-GGCAAATACTGGAGTATTCCATGGATTTTCAGGCCCG-3V
F61W 5V-CGGGCCTGAAAATCCATATAATACTCCAGTATGGGCCATAAAG-3V
5V-CTTTATGGCCCATACTGGAGTATTATATGGATTTTCAGGCCCG-3V
F77W 5V-GTAGATTGGAGAGAACTTAATAAGAAAACTCAAGACTTCTGGG-3V
5V-CCCAGAAGTCTTGAGTTTTCTTATTAAGTTCTCTCCAATCTAC-3V
F87W 5V-GAAAACTCAAGACTGGTGGGAAGTTCAATTAGGAATACCACATCCC-3V
5V-GGGATGTGGTATTCCTAATTGAACTTCCCACCAGTCTTGAGTTTTC-3V
F116W 5V-GGGTGATGCATATTGGTCAGTTCCCTTAGATAAAGAATTCAGG-3V
5V-CCTGAATTCTTTATCTAAGGGAACTGACCAATATGCATCACCC-3V
F124W 5V-CAGTTCCCTTAGATAAAGAATGGAGGAAGTACACTGC-3V
5V-GCAGTGTACTTCCTCCATTCTTTATCTAAGGGAACTG-3V
Y127W 5V-CCCTTAGATAAAGAGTTCAGGAAGTGGACTGCATTTACCATACC-3V
5V-GGTATGGTAAATGCAGTCCACTTCCTGAACTCTTTATCTAAGGG-3V
F130W 5V-GGAAGTACACTGCATGGACCATACCTAGTATAAACAATGAGACAC-3V
5V-GTGTCTCATTGTTTATACTAGGTATGGTCCATGCAGTGTACTTCC-3V
Y144W 5V-GACACCAGGGATTAGATGGCAGTACAATGTGCTTCC-3V
5V-GGAAGCACATTGTACTGCCATCTAATCCCTGGTGTC-3V
Y146W 5V-GGGATTAGATATCAGTGGAATGTGCTTCCACAGGG-3V
5V-CCCTGTGGAAGCACATTCCACTGATATCTAATCCC-3V
F171W 5V-GCATGACAAAAATCTTAGAGCCTTGGAGAAAACAAAATCCAGAC-3V
5V-GTCTGGATTTTGTTTTCTCCAAGGCTCTAAGATTTTTGTCATGC-3V
Y181W 5V-CCAGACATAGTTATCTGGCAATACATGGACGATTTGTATGTAGG-3V
5V-CCTACATACAAATCGTCCATGTATTGCCAGATAACTATGTCTGG-3V
Y183W 5V-CCAGACATAGTTATCTATCAATGGATGGACGATTTGTATGTAGG-3V
5V-CCTACATACAAATCGTCCATCCATTGATAGATAACTATGTCTGG-3V
Y188W 5V-CAATACATGGACGATTTGTGGGTAGGATCTGACTTAGAAATAGGG-3V
5V-CCCTATTTCTAAGTCAGATCCTACCCACAAATCGTCCATGTATTG-3V
F227W 5V-CATCAGAAAGAACCTCCATGGCTTTGGATGGGTTATGAACTCC-3V
5V-GGAGTTCATAACCCATCCAAAGCCATGGAGGTTCTTTCTGATG-3V
Y232W 5V-CCTTTGGATGGGTTGGGAACTCCATCCTGATAAATGG-3V
5V-CCATTTATCAGGATGGAGTTCCCAACCCATCCAAAGG-3V
pRT6 T58S 5V-GAGAATCCATACAATTCTCCAGTATTTGCC-3V
5V-GGCAAATACTGGAGAATTGTATGGATTCTC-3V
F61W 5V-CCATACAATACTCCAGTATGGGCCATAAAGAAAAAA-3V
5V-TTTTTTCTTTATGGCCCATACTGGAGTATTGTATGG-3V
F77W 5V-GGAGAAAATTAGTAGATTGGAGAGAACTTAATAAG-3V
5V-CTTATTAAGTTCTCTCCAATCTACTAATTTTCTCC-3V
F116W 5V-GTGGGTGATGCATATTGGTCAGTTCCCTTAGATG-3V
5V-CATCTAAGGGAACTGACCAATATGCATCACCCAC-3V
F124W 5V-GTTCCCTTAGATGAAGACTGGAGGAAGTATACTGC-3V
5V-GCAGTATACTTCCTCCAGTCTTCATCTAAGGGAAC-3V
F130W 5V-CAGGAAGTATACTGCATGGACCATACCTAGTATA-3V
5V-TATACTAGGTATGGTCCATGCAGTATACTTCCTG-3V
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viability using the trypan blue staining method.
RNA isolation, amplification, and nucleotide sequence
analysis
Culture supernatants were passed through 0.45-Al pore
size filters and treated with DNase A for 30 min to eliminate
input DNA. Total RNA was obtained from 20 Al of treated
transfection supernatants (Boom et al., 1990). RNA ampli-
fication was done with the one tube RT-polymerase chain
reaction (PCR) System (Titan, Boehringer Mannheim) using
primers 47RU (5V GTATTAGTAGGACCTACACCT 3V,
positions 2055–2075) and 59RD (5V ATGATTCCTAATG-CATATTGTGAGT 3V, complementary to positions 3622–
3646). Primers are numbered according to the sequence of
Ratner et al. (1985). These primers amplify a 1591-base pair
fragment. After reverse transcription at 50 jC for 30 min
and a 5-min incubation at 94 jC, samples were subjected to
35 rounds of amplification. Each cycle composed a 1 min-
denaturation step at 94 jC, a 1 min-annealing step at 55 jC,
and a 2 min-extension step at 72 jC. Nucleotide sequence
analysis of the amplified product was performed with
primers 14RD (5VGCACGATATCTAATCCTGGTGTCTCA
3V, complementary to positions 2540–2561), 3VRU (5V GC-
GGGATCCTGAAAATCCATACAATACTC 3V, positions
2278–2304), 15VRU (5V TAGATATCAGTACAATGTGCT-
TCCAC 3V, positions 2555–2580), 58RU (5V GCCA-
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2890), and 59RD (5VATGATTCCTAATGCATATTGT-
GAGT 3V complementary to positions 3622–3646) by
using the Big Dye Terminator Cycle Sequencing Kit
(Applied Biosystems) and an ABI-PRISM 377 DNA
sequencer.
Immunoblotting
Aliquots of 450 Al of cell culture supernatants previously
subjected to filtration through a 0.2-Am-pore size filter
(Millipore, Bedford, MA) were overlaid onto 300 Al of a
20% sucrose cushion and centrifuged at 25000  g for 2
h at 4 jC. Virus pellets or MT-4 cells collected at different
times after infection were resuspended in 80 mM Tris
buffer, pH 6.8, containing 2% sodium dodecyl sulfate
(SDS) and 1% glycerol, and then subjected to electropho-
resis in an SDS-polyacrylamide gel. Separated proteins
were electrotransferred to a polyvinylidene difluoride-type
membrane (Hybond-PVDF, Amersham), and probed with
mouse monoclonal antibodies against p24 or h-actin. De-
tection of membrane-bound antibodies was done using
anti-mouse IgG labeled with horseradish peroxidase, and
the reaction was developed with enhanced chemilumines-
cence detection reagents and Hyperfilm-ECL (Amersham).
The monoclonal antibodies to HIV-1 p24 and h-actin
were obtained from IBT Immunological and Biochemical
Testsystems GmbH (Reutlingen, Germany) and Sigma,
respectively.
Mutagenesis, expression, and purification of recombinant
RTs
Site-directed mutagenesis was carried out with the Quik-
Change Site-Directed Mutagenesis Kit (Stratagene) using
plasmid pRT6 (Quin˜ones-Mateu et al., 1997) as template and
the mutagenic primers shown in Table 4. The RT-coding
regions of pRT6 and p61F A have different nucleotide
sequences. Therefore, primers used to introduce mutations
in pRT6 were different from those used to mutagenize p61F
A, except in the case of Y146W, which was introduced in
both plasmids with the same set of primers. Amino acid
sequence differences between the RTs encoded within
plasmids pRT6 and p61F A are R83K, E122K, D123E,
K172R, R211K, L214F, R277K, K281R, E297K, V435I,
P468T, L469I, N471D, Y483L, L517I, N519S, A534T,
A554T, and I559V. None of these substitutions has been
shown to affect RT function. After mutagenesis, the RT-
coding regions were sequenced, and inserts containing the
appropriate mutations were cloned in the p51 expression
vector pT51H by following previously described proce-
dures (Martı´n-Herna´ndez et al., 1996; Mene´ndez-Arias,
1998). Purification of WT and mutant RTs was carried
out after independent expression of their subunits (Martı´n-
Herna´ndez et al., 1996; Olivares et al., 1999). All RTs were
purified as p66/p51 heterodimers. The 51-kDa polypeptidewas obtained with an extension of 14 amino acid residues at
its N-terminal end, which includes six consecutive histi-
dines to facilitate its purification by metal chelate affinity
chromatography.
Primer extension assays
The template/primer M_54/3TRP (sequences given in
Fig. 2) was used to determine DNA-dependent DNA poly-
merase activity of mutant RTs. 3TRP was labeled at its 5V
terminus with [g-32P]ATP with T4 polynucleotide kinase
and then annealed to M_54 in 150 mM NaCl and 150 mM
magnesium acetate as described (Martı´n-Herna´ndez et al.,
1997). Fifteen microliters of a solution containing 10–15
nM enzyme and 60 nM template/primer in 100 mM HEPES,
30 mM NaCl, 30 mM magnesium acetate, 130 mM
KCH3COO, 1 mM dithiothreitol, and 5% (w/v) polyethyl-
ene glycol 6000, pH 7.0, was incubated at 37 jC for 10 min.
Primer extensions were initiated by adding 15 Al of a
mixture containing the four dNTPs at a concentration of 1
mM each in 130 mM KCH3COO, 1 mM dithiothreitol, and
5% (w/v) polyethylene glycol 6000. Reactions were incu-
bated for 0–60 min. Aliquots of 5 Al were withdrawn at
different times and reactions were then stopped by adding 5
Al of 10 mM EDTA loading buffer containing 90% form-
amide. DNA synthesis products were separated on a 20%
polyacrylamide-urea gel and visualized by phosphorimag-
ing with a BAS 1500 scanner (Fuji).
Single nucleotide extension assays
The template/primer D2-47/PG5-25 (sequences given in
Table 2) was used. PG5–25 was 5V-end-labeled and
annealed to D2–47 as described above for M_54/3TRP.
Nucleotide incorporation assays were performed in 10 Al of
50 mM HEPES, pH 7.0, 15 mM NaCl, 15 mM magnesium
acetate, 130 mM KCH3COO, 1 mM dithiothreitol, and 5%
polyethylene glycol 6000. The template-primer concentra-
tion was 30 nM and the active enzyme concentration was
around 6 nM. Reactions were initiated by incubating the
enzyme with the corresponding annealed template-primer in
the absence of dNTP (10 min at 37 jC), and then followed
by the addition of appropriate dNTPs at various concen-
trations. The rate of product formation was measured for
10–14 different concentrations of the correct dNTP (dTTP).
Elongation reactions for the incorporation of dTTP were
carried out at 37 jC for 10–90 s. Under these conditions,
reactions were linear with respect to time and proportional
to the enzyme concentration. After incubation, reactions
were stopped by adding EDTA (5 mM final concentration),
followed by heat denaturation. Products were resolved by
electrophoresis in 20% polyacrylamide-urea gels and quan-
titated with a BAS 1500 scanner. Elongation measurements
were fitted to the Michaelis-Menten equation, and the kcat
and Km values were determined as previously described
(Martı´n-Herna´ndez et al., 1996).
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